Jack Bendheim, Executive Chairman of Phibro Animal Health (PAHC), has filed 136 Form 4 transactions, all in that single company. The pattern is one-sided: he has recorded $32,002,626.51 in total sales and zero purchases or acquisitions. The recent window, from April 15 through May 7, 2026, shows 23 open-market sales, with no buys.
The selling is steady and frequent. On April 15, he sold $206,985.42 and $46,431.97. Two days later, on April 16, he sold $283,141.49 and $101,520.42, plus a conversion of a derivative security valued at $0. The pace continued through late April: $304,136.72 and $89,943.91 on April 21, $382,184.70 on April 22, and $357,856.90 plus $22,969 on April 23. The largest single transaction in the stretch was $382,184.70 on April 22.
May brought more of the same. On May 5, he sold $349,070.80 and $43,739.24. May 6 saw $322,125.08 and $81,724.73. The final reported sales came on May 7, totaling $99,815.03, $55,505.20, and $64,247.58. The last filing, dated August 4, 2026, is a code "J" transaction worth $84,287.50, which is not an open-market sale or purchase. Across the entire record, Bendheim has never reported an open-market purchase of PAHC shares.
AI-assisted summary